Background: Combined pulmonary fibrosis and emphysema (CPFE) commonly coexists with connective tissue diseases (CTD), such as rheumatoid arthritis (RA). However, the risk factors contributing to the ...
Pulmonx Corporation (Nasdaq: LUNG) ("Pulmonx" or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported ...
Gross profit in the fourth quarter of 2024 was $17.6 million, compared to $14.4 million for the fourth quarter of 2023. Gross margin for the fourth quarter of 2024 was 74%, compared to 75% for the ...
Pulmonx Corporation Reports 2024 Financial Results With 22% Revenue Growth and Strong Q4 Performance
The company achieved a gross margin of 74% for both the fourth quarter and the full year, while U.S. revenue rose to $15.9 million in the fourth quarter, reflecting a 16% increase. Pulmonx added ...
“The whole experience made me feel gross and uncomfortable when I just wanted to relax and watch a movie. “I tried searching for a seat that didn’t have mold and couldn’t find one.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results